Showing results (151-160 of 277) with videos related to
Sort By:
Pageof 28
Radiology|February 27, 2019
Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)Christina Messiou, Jens Hillengass, Stefan Delorme, et al.Acta Oncologica (Stockholm, Sweden)|April 23, 2017
Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 studyRobin J Young, Saskia Litière, Michela Lia, et al.Rare Tumors|April 28, 2025
Comparison of MRI imaging features to differentiate degenerating fibroids from uterine leiomyosarcomasWilliam W Loughborough, Andrea G Rockall, Tanja T Gagliardi, et al.Cancer Chemotherapy and Pharmacology|February 7, 2013
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumorsShahneen K Sandhu, Kyri Papadopoulos, Peter C Fong, et al.The Oncologist|September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid TumorsSpyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.BMC Cancer|April 2, 2020
Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myelomaPriya Sriskandarajah, Alexis De Haven Brandon, Kenneth MacLeod, et al.Anti-Cancer Drugs|April 23, 2005
Proteasome: an emerging target for cancer therapyIvana Zavrski, Christian Jakob, Peter Schmid, et al.European Journal of Haematology|December 14, 2005
Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphomaUlrike Heider, Martin Kaiser, Jan Sterz, et al.European Journal of Haematology|December 11, 2008
Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatmentUlrike Heider, Martin Kaiser, Maren Mieth, et al.Journal of Cancer Research and Clinical Oncology|September 4, 2008
Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinaseIvana von Metzler, Holger Krebbel, Ulrike Kuckelkorn, et al.Pageof 28